Evolutionary determinants of cancer.
暂无分享,去创建一个
[1] Nigel F. Delaney,et al. Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.
[2] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[3] John R Yates,et al. The butterfly effect in cancer: A single base mutation can remodel the cell , 2015, Proceedings of the National Academy of Sciences.
[4] H. Kitano. Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.
[5] Brian Keith,et al. Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.
[6] V. Quaranta,et al. Integrative mathematical oncology , 2008, Nature Reviews Cancer.
[7] J. Goedert. Infectious Causes of Cancer , 2000, Infectious Disease.
[8] T. Holyoake,et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. , 2002, Blood.
[9] Sebastian Herzog,et al. BCL6 enables Ph+ acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition , 2011, Nature.
[10] Sean J Morrison,et al. Cancer stem cells: impact, heterogeneity, and uncertainty. , 2012, Cancer cell.
[11] Andrea Sottoriva,et al. Defining Stem Cell Dynamics in Models of Intestinal Tumor Initiation , 2013, Science.
[12] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[13] Jane Fridlyand,et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors , 2012, Nature.
[14] C. Cooper,et al. Steroid hormone receptors in prostate cancer: a hard habit to break? , 2009, Cancer cell.
[15] K. Weiss. Are the known chronic diseases related to the human lifespan and its evolution? , 1989, American journal of human biology : the official journal of the Human Biology Council.
[16] Hans Clevers,et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.
[17] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[18] Pier Paolo Di Fiore,et al. The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells , 2009, Cell.
[19] H. A. Rogoff,et al. Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.
[20] L. Israel. Tumour progression: random mutations or an integrated survival response to cellular stress conserved from unicellular organisms? , 1996, Journal of theoretical biology.
[21] Andrei Kucharavy,et al. Targeting the Adaptability of Heterogeneous Aneuploids , 2015, Cell.
[22] B. Stewart,et al. World cancer report 2014. , 2014 .
[23] T. Boehm. Design principles of adaptive immune systems , 2011, Nature Reviews Immunology.
[24] Dnmt3a Is Essential for Hematopoietic Stem Cell Differentiation , 2011 .
[25] 磯田 健志. Immunologically silent cancer clone transmission from mother to offspring , 2012 .
[26] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[27] R. Lewontin. The Units of Selection , 1970, The Structure and Confirmation of Evolutionary Theory.
[28] R. Doll,et al. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.
[29] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.
[30] Federica Madia,et al. Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans , 2011, Science Translational Medicine.
[31] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[32] A. S. Alvarado. Cellular Hyperproliferation and Cancer as Evolutionary Variables , 2012, Current Biology.
[33] Benjamin D. Simons,et al. Defining the mode of tumour growth by clonal analysis , 2012, Nature.
[34] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[35] Paz Polak,et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer , 2015, Nature.
[36] Kyle Summers,et al. Positive selection in the evolution of cancer , 2006, Biological reviews of the Cambridge Philosophical Society.
[37] A. Ashworth,et al. Genetic Interactions in Cancer Progression and Treatment , 2011, Cell.
[38] J. Nunemacher,et al. Optimal management of giant cell arteritis and polymyalgia rheumatica , 2012, Therapeutics and clinical risk management.
[39] Olivia Fletcher,et al. Architecture of inherited susceptibility to common cancer , 2010, Nature Reviews Cancer.
[40] B. Frieden,et al. Adaptive therapy. , 2009, Cancer research.
[41] Hans Clevers,et al. Plasticity within stem cell hierarchies in mammalian epithelia. , 2015, Trends in cell biology.
[42] R. Gillies,et al. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.
[43] N. Potter,et al. Genetic and Functional Diversity of Propagating Cells in Glioblastoma , 2014, Stem cell reports.
[44] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[45] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[46] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[47] J. Oldenburg,et al. Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). , 2007, Blood.
[48] Ville Mustonen,et al. The value of monitoring to control evolving populations , 2014, Proceedings of the National Academy of Sciences.
[49] David Basanta,et al. Exploiting evolution to treat drug resistance: combination therapy and the double bind. , 2011, Molecular pharmaceutics.
[50] Ronald A. DePinho,et al. The age of cancer , 2000, Nature.
[51] Patrik L. Ståhl,et al. Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. , 2011, The Journal of investigative dermatology.
[52] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[53] F. Demichelis,et al. Tumor clone dynamics in lethal prostate cancer , 2014, Science Translational Medicine.
[54] Mel Greaves,et al. Cancer causation: the Darwinian downside of past success? , 2002, The Lancet. Oncology.
[55] Jacques Monod,et al. Chance and Necessity , 1970 .
[56] เอกรัฐ รัฐฤทธิ์ธำรง. Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation , 2009 .
[57] P. Johnston,et al. Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.
[58] A. G. de Herreros,et al. Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature , 2013, Clinical Cancer Research.
[59] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[60] J. Krug,et al. Empirical fitness landscapes and the predictability of evolution , 2014, Nature Reviews Genetics.
[61] Z. Szallasi,et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.
[62] S. Alonso,et al. A scan for signatures of positive selection in candidate loci for skin pigmentation in humans. , 2006, Molecular biology and evolution.
[63] H. Rosing,et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Golub,et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.
[65] M. Pike,et al. Women's Reproductive Cancers in Evolutionary Context , 1994, The Quarterly Review of Biology.
[66] Roy Kishony,et al. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance , 2013, Nature Reviews Genetics.
[67] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[68] T. Enver,et al. Initiating and Cancer-Propagating Cells in TEL-AML1-Associated Childhood Leukemia , 2008, Science.
[69] F. Markowetz,et al. Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.
[70] Michelle R. Campbell,et al. A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection , 2013, Cell.
[71] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[72] Gideon Rechavi,et al. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[73] Guy S. Salvesen,et al. SnapShot: Caspases , 2011, Cell.
[74] Wan-Jin Lu,et al. p53 ancestry: gazing through an evolutionary lens , 2009, Nature Reviews Cancer.
[75] L. Foulds,et al. The natural history of cancer. , 1958, Journal of chronic diseases.
[76] B. Anokhin,et al. Naturally occurring tumours in the basal metazoan Hydra , 2014, Nature Communications.
[77] Patricia A. Johnson,et al. The hen as a model of ovarian cancer , 2013, Nature Reviews Cancer.
[78] Q. Waisfisz,et al. High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival , 2005, Clinical Cancer Research.
[79] S. Gould,et al. Punctuated equilibria: the tempo and mode of evolution reconsidered , 1977, Paleobiology.
[80] P. Rothwell,et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.
[81] R. Houlston,et al. Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia , 2013, Proceedings of the National Academy of Sciences.
[82] Benjamin Kerr,et al. Life cycles, fitness decoupling and the evolution of multicellularity , 2014, Nature.
[83] Simon Wan,et al. Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer , 2013, Clinical Cancer Research.
[84] M. Greaves. Does everyone develop covert cancer? , 2014, Nature Reviews Cancer.
[85] Thomas J. Hudson,et al. Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia , 2014, Nature.
[86] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[87] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[88] M. Archetti,et al. Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer , 2015, Proceedings of the National Academy of Sciences.
[89] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[90] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[91] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[92] F. Delsuc,et al. Phylogenomics and the reconstruction of the tree of life , 2005, Nature Reviews Genetics.
[93] M. Greaves. Infection, immune responses and the aetiology of childhood leukaemia , 2006, Nature Reviews Cancer.
[94] J. Losos,et al. CONVERGENCE, ADAPTATION, AND CONSTRAINT , 2011, Evolution; international journal of organic evolution.
[95] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[96] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[97] Luca Toschi,et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. , 2010, Cancer cell.
[98] Kristian Cibulskis,et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.
[99] L. Aaltonen,et al. Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors , 2012, Science.
[100] Kevin R Foster,et al. High relatedness maintains multicellular cooperation in a social amoeba by controlling cheater mutants , 2007, Proceedings of the National Academy of Sciences.
[101] S. Galavotti,et al. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells , 2015, Proceedings of the National Academy of Sciences.
[102] Jeffrey M. Rosen,et al. The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.
[103] M. Greaves,et al. Leukemia in twins: lessons in natural history. , 2003, Blood.
[104] M. Greaves. Was skin cancer a selective force for black pigmentation in early hominin evolution? , 2014, Proceedings of the Royal Society B: Biological Sciences.
[105] Sohrab P. Shah,et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution , 2014, Nature.
[106] Carissa A. Sanchez,et al. NSAIDs Modulate Clonal Evolution in Barrett's Esophagus , 2013, PLoS genetics.
[107] A. Sivachenko,et al. Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.
[108] C. Maley,et al. Peto's Paradox: evolution's prescription for cancer prevention. , 2011, Trends in ecology & evolution.
[109] C. Lineweaver,et al. Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors , 2011, Physical biology.
[110] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[111] C. Klein. Selection and adaptation during metastatic cancer progression , 2013, Nature.
[112] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[113] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[114] Douglas A Lauffenburger,et al. Addressing genetic tumor heterogeneity through computationally predictive combination therapy. , 2013, Cancer discovery.
[115] R. Poulsom,et al. Lineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution , 2013, Proceedings of the National Academy of Sciences.
[116] Manuel Hidalgo,et al. Tumor-initiating cells are rare in many human tumors. , 2010, Cell stem cell.
[117] M. Greaves. Cancer stem cells as ‘units of selection’ , 2012, Evolutionary applications.
[118] W. Birchmeier,et al. Wnt signaling in stem and cancer stem cells. , 2013, Current opinion in cell biology.
[119] J. Boomsma,et al. Genetic royal cheats in leaf-cutting ant societies , 2008, Proceedings of the National Academy of Sciences.
[120] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[121] S. Hankinson,et al. Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.
[122] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[123] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[124] Jane E. Visvader,et al. Cells of origin in cancer , 2011, Nature.
[125] Alissa M. Weaver,et al. Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.
[126] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[127] Angelo J. Canty,et al. Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.
[128] M. Nowak,et al. Dynamics of cancer progression , 2004, Nature Reviews Cancer.
[129] A. Tward,et al. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma , 2013, Cancer.
[130] K. Lewis. Persister cells, dormancy and infectious disease , 2007, Nature Reviews Microbiology.
[131] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[132] P. Oliveira,et al. Tumor clone dynamics in lethal prostate cancer. , 2017, European urology.
[133] Harold Varmus,et al. Addressing the Growing International Challenge of Cancer: A Multinational Perspective , 2013, Science Translational Medicine.
[134] Mel Greaves,et al. Cancer: The Evolutionary Legacy , 2000 .
[135] P. N. Rao,et al. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.
[136] Gavin Sherlock,et al. Quantitative evolutionary dynamics using high-resolution lineage tracking , 2015, Nature.
[137] F. Ayala,et al. Human Skin Pigmentation as an Adaptation to UV Radiation , 2010 .
[138] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[139] Roland Arnold,et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers , 2015, Nature Genetics.
[140] A. Krešo,et al. Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.
[141] Robert Axelrod,et al. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.
[142] Kyle Summers,et al. Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.
[143] Igor Shats,et al. Using a stem cell-based signature to guide therapeutic selection in cancer. , 2011, Cancer research.
[144] Gary D Bader,et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity , 2015, Proceedings of the National Academy of Sciences.
[145] N. Grishin,et al. Insights into the Evolution of Longevity from the Bowhead Whale Genome , 2015, Cell reports.
[146] K. Pienta,et al. Cancer as a complex adaptive system. , 1996, Medical hypotheses.
[147] Xiaoquan Wen,et al. Correction: A Map of Recent Positive Selection in the Human Genome , 2006, PLoS Biology.
[148] Th. Boveri,et al. The origin of malignant tumors , 1929 .
[149] Steven N. Austad,et al. Why do we age? , 2000, Nature.
[150] M. Nowak,et al. Evolutionary Dynamics of Biological Games , 2004, Science.
[151] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[152] David L Stern,et al. Is Genetic Evolution Predictable? , 2009, Science.
[153] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[154] Allon M. Klein,et al. Clonal dynamics of native haematopoiesis , 2014, Nature.
[155] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[156] Christopher J. R. Illingworth,et al. High-Definition Reconstruction of Clonal Composition in Cancer , 2014, Cell reports.
[157] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[158] David Basanta,et al. Exploiting ecological principles to better understand cancer progression and treatment , 2013, Interface Focus.
[159] Nicholas D. Socci,et al. Mad2-induced chromosome instability leads to lung tumor relapse after oncogene withdrawal , 2010, Nature.
[160] Bert Vogelstein,et al. Genetic instability and darwinian selection in tumours , 1999 .
[161] N. Navin,et al. Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.
[162] N. Rosenfeld,et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA , 2013, Nature.
[163] B. Stewart,et al. World Cancer Report , 2003 .
[164] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[165] Andreas Wagner,et al. Arrival of the Fittest: Solving Evolution's Greatest Puzzle , 2014 .
[166] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.
[167] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[168] Armand M. Leroi,et al. Cancer selection , 2003, Nature Reviews Cancer.
[169] M. Hochberg,et al. Cancer across the tree of life: cooperation and cheating in multicellularity , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.
[170] Robert J. Gillies,et al. A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.
[171] Hiroaki Kitano,et al. Biological robustness , 2008, Nature Reviews Genetics.
[172] J. Pritchard,et al. A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.
[173] R. Nusse,et al. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.
[174] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[175] L. Buss,et al. The evolution of individuality , 1987 .
[176] N. McGranahan,et al. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.
[177] S. Heiland,et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. , 2014, Cell stem cell.
[178] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[179] Valeria Souza,et al. Stress-Induced Mutagenesis in Bacteria , 2003, Science.
[180] Lars Hufnagel,et al. Spatial constraints control cell proliferation in tissues , 2014, Proceedings of the National Academy of Sciences.
[181] William R. Jacobs,et al. Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV , 2012, Cell.
[182] R. Sandberg,et al. Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.
[183] R. Michod. Darwinian Dynamics: Evolutionary Transitions in Fitness and Individuality , 1999 .
[184] D. Ward,et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. , 2011, Cancer research.
[185] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[186] Zhengdong D. Zhang,et al. Comparative genetics of longevity and cancer: insights from long-lived rodents , 2014, Nature Reviews Genetics.
[187] John Doyle,et al. Complexity and robustness , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[188] Mel Greaves,et al. Darwinian medicine: a case for cancer , 2007, Nature Reviews Cancer.
[189] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[190] P. Pelicci,et al. Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content , 2010, Cell.
[191] John Cairns,et al. Mutation selection and the natural history of cancer , 1975, Nature.
[192] Michael S. Breen,et al. Epistasis as the primary factor in molecular evolution , 2012, Nature.
[193] Jeff Gore,et al. Turning ecology and evolution against cancer , 2014, Nature Reviews Cancer.
[194] Diethard Tautz,et al. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa , 2010, BMC Biology.
[195] T. Bosch. Hydra and the evolution of stem cells , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[196] M. Gurven,et al. Longevity Among Hunter‐ Gatherers: A Cross‐Cultural Examination , 2007 .
[197] Yoshitaka Narita,et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. , 2010, Genes & development.
[198] Andreas Trumpp,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[199] Charles Swanton,et al. Intratumor Heterogeneity: Seeing the Wood for the Trees , 2012, Science Translational Medicine.
[200] B. Rinkevich. A critical approach to the definition of Darwinian units of selection. , 2000, The Biological bulletin.
[201] P. Campbell,et al. Single-cell mutational profiling and clonal phylogeny in cancer , 2013, Genome research.
[202] A. Ullrich,et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.
[203] G. B. Golding,et al. Antibiotic resistance is ancient , 2011, Nature.
[204] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .